January 24, 2020
Amgen Astellas BioPharma, a joint venture launched in 2013 by US biotech powerhouse Amgen and Astellas Pharma, will become Amgen’s wholly owned subsidiary on April 1, the pair announced jointly on January 23. As per their initial strategic alliance deal...read more